JNJ · News · 20261020N

Shockwave C2 Aero Launch

JOHNSON & JOHNSON · 2026-10-20 · Importance 34 · Surprise 42 · In source text

Johnson & Johnson launched the Shockwave C2 Aero Fly Coronary IVL Catheter in the United States for calcified coronary lesions. The device delivers pulses at 2 Hz, twice the speed of its predecessor, and is designed to cut IVL treatment time in half. Faster pulse delivery and shorter rest periods are intended to reduce procedure-induced ischemic time and improve cath-lab efficiency. The launch builds on Shockwave Medical technology acquired by Johnson & Johnson in 2024 and follows strong global Shockwave sales.

Key facts

• The Shockwave C2 Aero Fly device delivers pulses twice as fast than prior versions and reduces pause times between cycles, enhancing efficiency in cath labs and designed to treat calcified coronary plaques faster. source
• Johnson & Johnson introduced the Shockwave C2 Aero Fly Coronary IVL Catheter in the U.S. for calcified coronary lesions. source
• The Shockwave C2 Aero Fly Coronary IVL Catheter delivers pulses at 2 Hz, cutting IVL treatment time in half. source
• Shockwave C2 Aero Fly builds on features of Shockwave C2 Aero, featuring leading deliverability, crossability and repositioning capabilities to improve efficiency in calcium modification treatment of coronary artery disease. source
• Johnson & Johnson acquired Shockwave Medical in 2024. source

Impact estimates